Giovanni Antonini

Pubblicazioni

Titolo	Pubblicato in	Anno
A 5-year clinical follow-up study from the Italian National Registry for FSHD	JOURNAL OF NEUROLOGY	2021
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension	NEUROLOGY	2021
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy	ORPHANET JOURNAL OF RARE DISEASES	2021
ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country	GENES	2021
The neurophysiological lesson from the Italian CIDP database	NEUROLOGICAL SCIENCES	2021
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP	JOURNAL OF NEUROLOGY	2021
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation	NEUROLOGICAL SCIENCES	2021
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial	LANCET NEUROLOGY	2021
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis	CELLS	2021
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome. An international observational study	JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY	2021
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP	NEUROLOGICAL SCIENCES	2021
The unfolded protein response in amyotrophic later sclerosis. results of a phase 2 trial	BRAIN	2021
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials	EUROPEAN JOURNAL OF NEUROLOGY	2021
Immune-mediated necrotizing myopathy (IMNM): a myopathological challenge	AUTOIMMUNITY REVIEWS	2021
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study	MUSCLE & NERVE	2021
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients	AUTOIMMUNITY REVIEWS	2020
Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab	JOURNAL OF NEUROLOGY	2020
Impact of environmental factors and physical activity on disability and quality of life in CIDP	JOURNAL OF NEUROLOGY	2020
Telemedicine for neuromuscular disorders during the COVID-19 outbreak	JOURNAL OF NEUROLOGY	2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY	2020

Pubblicazioni

Progetti di Ricerca